-
-
-
-
-
-
-
ChemoCentryx (CCXI) Closes Up 7% on Filing of Amendment to NDA Submission and Extension of PDUFA for Avacopan
-
-
-
-
-
-
-
ChemoCentryx to Present at Two Upcoming Investor Conferences
-
-
-
-
-
-
-
ChemoCentryx (CCXI) PT Lowered to $95 at Raymond James
-
-
-
-
-
-
-
Raymond James Starts ChemoCentryx (CCXI) at Strong Buy
-
27,179 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All